Nextcure Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Nextcure Inc's ROI in the second quarter of 2026?
Nextcure Inc recorded a cumulative net loss of $-43 million during 12 months ending in the second quarter of 2026, resulting in a negative return on investment (ROI) of -148.01%.

Within the Healthcare sector 672 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 2292 to 4193.

Definition and Formula of Return on Investment

Select the Comparisons :

None ▼

Select the Ratio:

Return on Investment ROI▼

None ▼

Return on Investment ROI▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Investment	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Investment Change TTM	-54.02 %	-55.5 %	-52.46 %	-50.47 %	-44.4 %
Y / Y Net Income Change TTM	-	-	-	-	-
Investment (TTM) in Millions	16	31	40	29	37
Return On Investment (TTM)	-148.01 %	-160.51 %	-134.13 %	-117.07 %	-96.99 %
NXTC's Overall Ranking	# 4193	# 2292	# 3356	# 3821	# 3292
Seq. Investment Change TTM	-15.2 %	-18.2 %	-15.98 %	-21.12 %	-17.92 %
Seq. Net Income Change TTM	-	-	-	-	-
Net Income (TTM) in Millions	-43	-55	-56	-58	-61

NXTC Company Profile >> Back to NXTC Roi Comparisons >> See Annual NXTC Return On Investment

Return On Investment NXTC's Ranking
Within:	No.
Industry	# 306
Sector	# 673
Overall	# 4193

Return On Investment Statistics
High	Average	Low
-6.78 %	-50.66 %	-160.51 %
(Mar 31 2020)		(Mar 31 2026)

Financial Statements
Nextcure Inc's II. Quarter Investments	$ 16 Millions	NXTC's Balance sheet
Nextcure Inc's II. Quarter Income	$ -15 Millions	Quarterly NXTC's Income Statement
NXTC's Income by Division		See NXTC's Income by Division

NXTC Annual Return On Investment	(Dec 31 2025) 2025	(Dec 31 2024) 2024	(Dec 31 2023) 2023	(Dec 31 2022) 2022	(Dec 31 2021) 2021
Total Investments in Millions	40	71	121	175	236
Y / Y Investment Growth	-44.43 %	-41.16 %	-30.78 %	-25.76 %	-20.43 %
Net Income in Millions	-56	-56	-63	-75	-69
Y / Y Net Income Growth	-	-	-	-	-
Annual Return On Investment	-140.96 %	-78.07 %	-51.77 %	-42.7 %	-29.43 %

Annual Roi Comment

Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
NXTC's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for NXTC's Competitors
Subscribers only: Roi for Nextcure Inc's Suppliers
Subscribers only: Return On Investment for NXTC's Customers

Other Ratios
NXTC's Roa	NXTC's Inventory Turnover Ratio	NXTC's Growth Rates	NXTC's Dividend Statistics
	NXTC's Profitability Ratios	NXTC's Asset Turnover Ratio	NXTC's Dividend Growth
NXTC's Roe	NXTC's Valuation Ratios	NXTC's Financial Strength Ratios	NXTC's Dividend Payout Ratio

Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector

ROI

Date modified: 2026-09-08T04:25:33+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.